In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis (Q43562263)

24 November 2017

title

In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis (English)

1 reference

Mycobacterium tuberculosis

24 November 2017

main subject

0 references

author name string

Rodríguez JC

1 reference

24 November 2017

Ruiz M

1 reference

24 November 2017

Climent A

1 reference

24 November 2017

Royo G

1 reference

24 November 2017

publication date

1 March 2001

1 reference

International Journal of Antimicrobial Agents

24 November 2017

published in

1 reference

24 November 2017

1 reference

24 November 2017

1 reference

24 November 2017

page(s)

229-231

1 reference

Tuberculosis at the end of the twentieth century

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900337-X

7 January 2021

Prospective study of drug-resistant tuberculosis in a Spanish urban population including patients at risk for HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900337-X

7 January 2021

Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900337-X

7 January 2021

Newly documented antimicrobial activity of quinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900337-X

7 January 2021

Activity of quinolones against mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900337-X

7 January 2021

The Clinical Use of Fluoroquinolones for the Treatment of Mycobacterial Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900337-X

7 January 2021

Mycobacterium tuberculosis: evolution of resistance in our environment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900337-X

7 January 2021

Current practices in mycobacteriology: results of a survey of state public health laboratories

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900337-X

7 January 2021

Tuberculosis susceptibility patterns, predictors of multidrug resistance, and implications for initial therapeutic regimens at a New York City hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900337-X

7 January 2021

Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900337-X

7 January 2021

Prolonged ciprofloxacin therapy fails to prevent reactivation tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900337-X

7 January 2021

Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900337-X

7 January 2021

Minimal inhibitory concentrations of rifabutin, ciprofloxacin, and ofloxacin against Mycobacterium tuberculosis isolated before treatment of patients in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900337-X

7 January 2021

Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900337-X

7 January 2021

In vitro activity of the new quinolone lomefloxacin against Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900337-X

7 January 2021

Ciprofloxacin susceptibility testing by MIC and disk elution of drug-resistant Mycobacterium tuberculosis and Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900337-X

7 January 2021

Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900337-X

7 January 2021

Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: effects of a C-8 methoxyl group on survival in liquid media and in human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900337-X

7 January 2021

In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900337-X

7 January 2021

10.1016/S0924-8579(00)00337-X

Identifiers

DOI

1 reference

24 November 2017

1 reference